PD-166326

PD-166326 Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name PD-166326
Generic PD-166326
Type
Formula C21H16Cl2N4O2
Weight Average: 427.283
Monoisotopic: 426.06503119
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
PD-166326
PD-166326

Innovators Monograph

You find simplified version here PD-166326



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=447700
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99444810
https://www.chemspider.com/Chemical-Structure.394719.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3085
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL327127
https://zinc.docking.org/substances/ZINC000002047503
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/P16
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE
4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide
4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide
4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE
(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE
4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile
N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE
N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide
5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide
Glucose tolerance test - non-pregnant
Urine protein electrophoresis test
Lepromin skin test
Capillary sample
Endotracheal intubation
Toxoplasma blood test
Triglyceride level
Neurological Exam
Plasma amino acids
MTHFR Mutation Test
Scedosporium Infection
Unresectable lung origin Progressive Neuroendocrine Tumors
Rubella
Cerumen impaction
Invasive Fungal Infections
Locally advanced disease has progressed during or following platinum-containing chemotherapy urothelial carcinoma (UC)
Severe Hidradenitis Suppurativa
Creatinine Clearance 5-15 mL/min
Amoebic Liver Abscess
Productive cough